| SARS-CoV-2 delta and omicron variants alter trophoblast cell fusion and syncytiotrophoblast dynamics : new insights into placental vulnerability | Cell death and disease |  | | 2025 | 48 | 95 |
|
| One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | | | 2024 | 83 | 160 |
|
| Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses | Biomedicine & pharmacotherapy | | | 2023 | 266 | 182 |
|
| SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses | EBioMedicine | | | 2023 | 128 | 271 |
|
| Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species | Virus research | | | 2023 | 55 | 231 |
|
| Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant | Microbiology spectrum | | | 2022 | 281 | 331 |
|
| A qualitative RT-PCR assay for the specific identification of the SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern | Journal of clinical virology | | | 2022 | 78 | 282 |
|
| Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study | PloS one | | | 2022 | 379 | 156 |
|
| Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature | | | 2022 | 1,464 | 234 |
|
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | | | 2022 | 297 | 240 |
|
| SARS-CoV-2 antigen-detecting rapid tests for the delta variant | The Lancet microbe | | | 2022 | 323 | 168 |
|
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | | | 2021 | 533 | 381 |
|
| SARS-CoV-2 rapid diagnostic tests for emerging variants | The Lancet. Microbe | | | 2021 | 508 | 161 |
|
